HBP.TO
Helix Biopharma Corp
Price:  
0.19 
CAD
Volume:  
30,860.00
Canada | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

HBP.TO WACC - Weighted Average Cost of Capital

The WACC of Helix Biopharma Corp (HBP.TO) is 6.8%.

The Cost of Equity of Helix Biopharma Corp (HBP.TO) is 9.85%.
The Cost of Debt of Helix Biopharma Corp (HBP.TO) is 5.00%.

Range Selected
Cost of equity 8.20% - 11.50% 9.85%
Tax rate 25.90% - 26.50% 26.20%
Cost of debt 5.00% - 5.00% 5.00%
WACC 6.0% - 7.6% 6.8%
WACC

HBP.TO WACC calculation

Category Low High
Long-term bond rate 3.3% 3.8%
Equity market risk premium 5.1% 6.1%
Adjusted beta 0.97 1.18
Additional risk adjustments 0.0% 0.5%
Cost of equity 8.20% 11.50%
Tax rate 25.90% 26.50%
Debt/Equity ratio 1 1
Cost of debt 5.00% 5.00%
After-tax WACC 6.0% 7.6%
Selected WACC 6.8%